1. Home
  2. CLRB vs FEBO Comparison

CLRB vs FEBO Comparison

Compare CLRB & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • FEBO
  • Stock Information
  • Founded
  • CLRB 2002
  • FEBO 1993
  • Country
  • CLRB United States
  • FEBO Hong Kong
  • Employees
  • CLRB N/A
  • FEBO N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • FEBO
  • Sector
  • CLRB Health Care
  • FEBO
  • Exchange
  • CLRB Nasdaq
  • FEBO Nasdaq
  • Market Cap
  • CLRB 12.5M
  • FEBO 12.7M
  • IPO Year
  • CLRB N/A
  • FEBO 2023
  • Fundamental
  • Price
  • CLRB $0.36
  • FEBO $1.20
  • Analyst Decision
  • CLRB Hold
  • FEBO
  • Analyst Count
  • CLRB 2
  • FEBO 0
  • Target Price
  • CLRB N/A
  • FEBO N/A
  • AVG Volume (30 Days)
  • CLRB 34.3M
  • FEBO 7.9K
  • Earning Date
  • CLRB 05-13-2025
  • FEBO 06-17-2025
  • Dividend Yield
  • CLRB N/A
  • FEBO N/A
  • EPS Growth
  • CLRB N/A
  • FEBO N/A
  • EPS
  • CLRB N/A
  • FEBO N/A
  • Revenue
  • CLRB N/A
  • FEBO $17,110,653.00
  • Revenue This Year
  • CLRB N/A
  • FEBO N/A
  • Revenue Next Year
  • CLRB N/A
  • FEBO N/A
  • P/E Ratio
  • CLRB N/A
  • FEBO N/A
  • Revenue Growth
  • CLRB N/A
  • FEBO 11.58
  • 52 Week Low
  • CLRB $0.22
  • FEBO $0.93
  • 52 Week High
  • CLRB $3.42
  • FEBO $17.68
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 61.13
  • FEBO 49.74
  • Support Level
  • CLRB $0.23
  • FEBO $1.11
  • Resistance Level
  • CLRB $0.69
  • FEBO $1.40
  • Average True Range (ATR)
  • CLRB 0.05
  • FEBO 0.13
  • MACD
  • CLRB 0.02
  • FEBO -0.01
  • Stochastic Oscillator
  • CLRB 26.84
  • FEBO 39.76

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care c principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: